
Selective growth-hormone secretagogue studied in GH-release research.

CJC-1295 without DAC is a growth hormone-releasing hormone (GHRH) analog. Research examines short-acting, pulsatile growth-hormone release and how it differs from the longer-acting DAC version.
Removing DAC gives CJC-1295 a shorter duration of action. Research examines how a short-acting GHRH analog affects pulsatile growth-hormone release and related markers.
Study designs differ in model, route, timing, concentration, and measured endpoints. The original methods section should define the setup.
These notes are a starting point, not a laboratory protocol or medical guidance. Check the primary sources, your institution’s procedures, and applicable regulations before planning any work.